Skip to content
Nonprofiteer
← PARTNERSHIP FOR CURES

Form 990 for tax year 2024

Filed by PARTNERSHIP FOR CURES.

Totals

Total revenue
$3,881,316
Total expenses
$1,310,247
Contributions and grants received
$3,555,268
Grants paid
$644,592
Program service revenue
$0
Investment income
$241,482
Other revenue
$84,566
Total assets, end of year
$7,498,255
Total liabilities, end of year
$1,480,635
Net assets or fund balances, end of year
$6,017,620
Program services expenses (Part IX)
$1,130,455
Management and general expenses
$112,766
Fundraising expenses
$67,026
Program service expenses (Part III)
$1,130,455

Program services were 86.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $3,555,268

  • 3 · Investment income

    total $241,482 · excluded $241,482

  • 8a · Fundraising events: gross income

    $116,009

  • 8b · Fundraising events: direct expenses

    $31,443

  • 8c · Net income from fundraising events

    total $84,566 · excluded $84,566

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $255,226 · program services $255,226

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $389,366 · program services $389,366

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $212,414 · program services $139,131 · management and general $42,483 · fundraising $30,800

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $220,233 · program services $171,781 · management and general $37,440 · fundraising $11,012

  • 8 · Pension plan contributions

    total $0

  • 9 · Other employee benefits

    total $38,262 · program services $27,740 · management and general $7,270 · fundraising $3,252

  • 10 · Payroll taxes

    total $30,901 · program services $22,346 · management and general $5,675 · fundraising $2,880

  • 11a · Fees: management

    total $22,555 · program services $20,250 · management and general $2,255 · fundraising $50

  • 11b · Fees: legal

    total $0

  • 11c · Fees: accounting

    total $21,841 · program services $16,381 · management and general $4,368 · fundraising $1,092

  • 11d · Fees: lobbying

    total $0

  • 11f · Fees: investment management

    total $0

  • 11g · Fees: other

    total $0

  • 12 · Advertising and promotion

    total $0

  • 13 · Office expenses

    total $15,792 · program services $10,827 · management and general $3,094 · fundraising $1,871

  • 14 · Information technology

    total $3,169 · program services $1,243 · management and general $1,780 · fundraising $146

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $36,944 · program services $27,708 · management and general $7,389 · fundraising $1,847

  • 17 · Travel

    total $0

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $3,724 · program services $3,661 · fundraising $63

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $628 · program services $596 · management and general $16 · fundraising $16

  • 23 · Insurance

    total $3,425 · program services $2,569 · management and general $685 · fundraising $171

  • 24a · Other expenses: Program development

    total $54,209 · program services $40,461 · fundraising $13,748

  • 24b · Other expenses: Other

    total $1,558 · program services $1,169 · management and general $311 · fundraising $78

  • 24e · All other expenses

    total $0

Balance sheet

Part X, book values.

  • 2 · Savings and temporary cash investments

    beginning of year $1,519,133 · end of year $1,394,531

  • 3 · Pledges and grants receivable

    beginning of year $138,366 · end of year $1,299,397

  • 9 · Prepaid expenses and deferred charges

    beginning of year $3,602 · end of year $5,342

  • 10a · Land, buildings and equipment: cost or other basis

    $153,627

  • 10b · Land, buildings and equipment: accumulated depreciation

    $9,517

  • 10c · Land, buildings and equipment, net

    beginning of year $942 · end of year $144,110

  • 11 · Investments: publicly traded securities

    beginning of year $3,190,547 · end of year $4,601,842

  • 15 · Other assets

    beginning of year $40,539 · end of year $53,033

  • 17 · Accounts payable and accrued expenses

    beginning of year $34,282 · end of year $182,569

  • 18 · Grants payable

    beginning of year $1,424,492 · end of year $1,298,066

  • 27 · Net assets without donor restrictions

    beginning of year $1,129,127 · end of year $1,657,072

  • 28 · Net assets with donor restrictions

    beginning of year $2,305,228 · end of year $4,360,548

Mission and programs · 2024

Mission

Cures Within Reach leverages the speed, safety and cost-effectiveness of testing approved therapies for new indications/diseases without effective treatment driving more treatments quicker to more patients.

Activities or mission (Part I)

To help patients by raising funds to find, vet, finance manage pilot human clinical trials that test already approved drugs, devices and other products to deliver fast, safe and affordable treatments for both common

  • Repurposing research In its main area of focus, the organization catalyzes clinical trials testing approved therapies by finding and facilitating these proof-of-concept clinical trials that, when succesful, catalyze follow-on funding for further trials and publications in order to allow broad patient use. In FY 2025 11 new clinical repurposing trials were signed in infectious disease, maternal health, neurology, oncology, rare disease and other disease areas, 9 clinical trials were completed, and 41 trials were still in progress for a total of 52 ongoing trials as of July 31, 2025.

    Expenses $1,130,455 · Grants $644,592

As filed on the 2024 return.

Listed in Part VII

  • Barbara Goodman

    President and CEO

    Total calculated
    $213,533
    From this org
    $205,320
    From related orgs
    $0
    Other
    $8,213
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $191,100
    Bonus
    $14,220
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $8,213
    Filer's total
    $213,533

  • Margaret Christie

    Chairman

    Total calculated
    $0
    Hours/week
    2

  • Matthew Rich

    Treasurer

    Total calculated
    $0
    Hours/week
    1

  • Lucy Mancini-Newell

    Secretary

    Total calculated
    $0
    Hours/week
    1

  • Kristina Allikmets

    Director

    Total calculated
    $0
    Hours/week
    1

  • Steve Braun

    Director

    Total calculated
    $0
    Hours/week
    1

  • Don Lo

    Director

    Total calculated
    $0
    Hours/week
    1

  • Robert Metz

    Director

    Total calculated
    $0
    Hours/week
    1

  • Nancy Sullivan

    Director

    Total calculated
    $0
    Hours/week
    1

  • Eric Waehner

    Director

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 2 · Substantiation required before reimbursing expenses
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Provenance

Return type
form_990
Tax year
2024
Filed
11 December 2025
IRS schema version
2024v5.1
Source object
202513459349300311

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.